NCT06797284 The Impact of Light, Electrical, and Magnetic Neuroregulation Interventions on Sleep-wake Disorders
| NCT ID | NCT06797284 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Second Affiliated Hospital of Soochow University |
| Condition | Insomnia Chronic |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2025-02-01 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2025-02-01 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Carry out precise and effective neuromodulation interventions, and develop new neuromodulation technologies for sleep disorders. Use phototherapy, transcranial electrical/magnetic stimulation and other therapies to conduct self-controlled intervention studies on insomnia, narcolepsy, and rapid eye movement sleep behavior disorder .
Eligibility Criteria
Inclusion Criteria: \- Patients with insomnia, narcolepsy,and RBD that have been clearly diagnosed by specialists should sign the informed consent form. Exclusion Criteria: 1. Patients with major neurological diseases such as multi-infarct dementia, Huntington\'s disease, normal pressure hydrocephalus, brain tumors, progressive supranuclear palsy, epilepsy, subdural hematoma, multiple sclerosis, or those who have sustained neurological dysfunction or known structural brain abnormalities after significant head trauma are excluded. 2. A history of major depressive disorder or bipolar disorder within the past year, as defined in DSM-IV criteria. A history of schizophrenia (meeting DSM-IV criteria). 3. History of severe drug or alcohol abuse within the past year; 4. Any significant systemic illness or unstable medical condition that may make it difficult to comply with the protocol, such as severe autoimmune diseases or a history of cancer. 5. Have significant hearing, visual, or cognitive impairments, or are unable to participate in interviews in a meaningful way.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06797284 clinical trial?
This trial is open to participants of all sexes, aged 8 Years or older, up to 75 Years, studying Insomnia Chronic. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06797284 currently recruiting?
Yes, NCT06797284 is actively recruiting participants. Contact the research team at liuchunfeng@suda.edu.cn for enrollment information.
Where is the NCT06797284 trial being conducted?
This trial is being conducted at Suzhou, China.
Who is sponsoring the NCT06797284 clinical trial?
NCT06797284 is sponsored by Second Affiliated Hospital of Soochow University. The trial plans to enroll 20 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.